More than 35,000 people die annually in the European Union due to infections resistant to antibiotics, a number comparable to deaths from flu, tuberculosis, and HIV combined. This alarming statistic comes from the European Centre for Disease Prevention and Control's (ECDC) report on antimicrobial resistance and consumption. The ECDC warns that progress in reducing antibiotic consumption in 2025 is insufficient to meet the EU's 2030 targets.
The ECDC report, released on the European Antibiotic Awareness Day, estimates that 4.3 million patients acquire at least one healthcare-associated infection during hospital stays each year. One in three microorganisms detected in these infections are bacteria resistant to important antibiotics, limiting treatment options. The report emphasizes that 70% of the impact of antimicrobial resistance on public health is due to healthcare-associated infections caused by multi-resistant bacteria.
The total consumption of antibiotics decreased by 5% in 2025 compared to 2019, but this reduction is not enough to achieve the EU's 2030 goal of a 20% decrease. The ECDC warns that without robust and rapid public health actions, it is unlikely that the EU's targets for antimicrobial resistance will be met by 2030. This will lead to an increase in infections caused by antibiotic-resistant bacteria, making treatment more challenging and increasing related deaths.
According to the ECDC, 90% of total antibiotic consumption occurs in outpatient settings, often for viral infections like SARS-CoV-2 and influenza, for which antibiotics are ineffective. The report highlights that babies and preschool children are frequently exposed to antibiotics, although many common childhood infections do not require them. In 2025, the estimated incidence of bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the EU increased by 72% compared to 2019.
The ECDC report identifies carbapenem-resistant infections, such as those caused by K. pneumoniae and Escherichia coli, as a significant threat to patients due to their high mortality rates. The center warns that new strains of bacteria resistant to multiple antibiotics are emerging, severely limiting treatment options for infected patients. This situation could lead to a return to the pre-antibiotic era, making many medical procedures, including organ transplants and cancer chemotherapy, extremely difficult or impossible to perform safely.
The ECDC emphasizes that 50% of healthcare-associated infections caused by multi-resistant bacteria could be prevented with adequate infection prevention and control measures. The report stresses that antibiotics should only be used to treat bacterial infections when medically indicated, as they are ineffective against viral infections. The center urges robust public health actions to address the growing threat of antimicrobial resistance.
The ECDC's findings underscore the urgent need for sustained efforts to combat antimicrobial resistance. Without effective antibiotics, many medical advancements could be compromised, leading to increased mortality and morbidity. The report serves as a call to action for policymakers, healthcare professionals, and the public to work together to address this critical public health issue.
Key points
- 35,000 people die annually in the EU due to antibiotic-resistant infections
- Insufficient progress in reducing antibiotic consumption to meet EU 2030 targets
- 90% of antibiotic consumption occurs in outpatient settings, often for viral infections
Reporting sources
- Resistência a antibióticos mata 35 mil pessoas por ano · RecordTV Cabo Verde